180 Life Sciences Corp. 作為一家臨床階段的生物科技公司開展業務,致力於開發新型藥物,以滿足發炎性疾病、纖維化和疼痛領域尚未滿足的需求。該公司的業務是利用來自牛津大學、希伯來大學和史丹福大學在治療領域知名專家的綜合專業知識。公司總部設於加州帕羅奧圖。公司於2017年6月7日上市。該公司透過其iGaming技術平台專注於iGaming產業。此外,公司也持續評估其生物技術資產的貨幣化策略。
ATNF stock price ended at $0 on 星期一, after dropping NaN%
On the latest trading day Aug 24, 2026, the stock price of ATNF fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for ATNF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.